Back
Global Payments Vs. Spyre Therapeutics Industry Stock Comparison
Sell
47
GPN
Global Payments
Last Price:
101.01
Seasonality Move:
8.66%
Buy
59
SYRE
Spyre Therapeutics
Last Price:
28.46
Seasonality Move:
-2.85%
Sell
47
Global Payments (GPN)
is a Sell
Is Global Payments a Buy, Sell or Hold?
- The current Global Payments [GPN] share price is $97.67. The Score for GPN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- GPN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $29.04. The Score for SYRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GPN Stock Price Chart
What is Global Payments's stock price today?
-
The Global Payments share price today is $97.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPN is experiencing slight buying pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $29.04
The current trend is moderately bearish and SYRE is experiencing slight buying pressure.
GPN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.93 | Sell |
Relative Strength Index (14 RSI): | 30.33 | Sell |
Chaikin Money Flow: | 1308170 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (105.14 - 112.7) | Sell |
Bollinger Bands (100): | (96.77 - 109.13) | Sell |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.41 | Buy |
Relative Strength Index (14 RSI): | 53.02 | Buy |
Chaikin Money Flow: | 71063 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.98 - 29.52) | Buy |
Bollinger Bands (100): | (25.44 - 33.84) | Sell |
GPN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 107.06 | Sell |
20-day SMA: | 108.72 | Sell |
50-day SMA: | 105.36 | Sell |
200-day SMA: | 116.09 | Sell |
8-day EMA: | 104.67 | Sell |
20-day EMA: | 107.09 | Sell |
50-day EMA: | 106.24 | Sell |
200-day EMA: | 110.74 | Sell |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.1 | Sell |
20-day SMA: | 28.66 | Buy |
50-day SMA: | 27.88 | Buy |
200-day SMA: | 29.31 | Sell |
8-day EMA: | 28.88 | Buy |
20-day EMA: | 28.56 | Buy |
50-day EMA: | 28.37 | Buy |
200-day EMA: | 27.36 | Buy |
Global Payments Earnings Growth & GPN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.39 per share, an increase next quarter of $0.35 per share, an increase this year of $1.23 per share, and an increase next year of $1.33 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.24 per share, an increase this year of $9.51 per share, and an increase next year of $0.02 per share.
Global Payments Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |